Danish Tobacco Stock News

Carlsberg (CPSE:CARL B) has posted its FY 2025 numbers with second half revenue of DKK 43.2b, basic EPS of DKK 18.10 and net income of DKK 2,393m, while the first half delivered revenue of DKK 45.9b, basic EPS of DKK 26.95 and net income of DKK 3,562m. The company has seen first half revenue move from DKK 38.8b in 2024 with basic EPS of DKK 28.08 and net income of DKK 3,739m to DKK 45.9b in 2025, which sets the scene for investors to focus on how current margins and expectations for future...

Demant A/S has released its full-year 2025 results, reporting sales of DKK 22,971 million, up from DKK 22,419 million a year earlier, while net income fell to DKK 1,545 million and basic earnings per share from continuing operations declined to DKK 11.2. The combination of higher sales but lower net income and earnings per share highlights shifting cost, margin or mix effects that may reshape how investors view Demant’s underlying earnings quality. We’ll now examine how Demant’s higher sales...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Danske Bank has completed its DKK 5,000,000,000 share buy-back programme, repurchasing 19,179,623 shares that are expected to be cancelled subject to shareholder approval at the March 26, 2026 annual general meeting. This move underscores a capital position that allows meaningful cash returns to investors and signals management’s confidence in the bank’s current trajectory. We’ll now examine how the completed DKK 5,000,000,000 buy-back and planned share cancellation shape Danske Bank’s...

Recently, Ambu’s CEO Britt Meelby Jensen joined a Danish life science delegation to China, presenting a new Chinese-made endoscope as part of efforts to deepen cooperation and diversify the company’s global value chain away from a more difficult US market. This move highlights how Ambu is reconfiguring its manufacturing and market exposure to tap Chinese healthcare demand while reducing reliance on a single geography. We’ll now examine how Ambu’s increased focus on Chinese manufacturing and...

Key Insights The considerable ownership by individual investors in TORM indicates that they collectively have a greater...

It's not a stretch to say that Carlsberg A/S' ( CPH:CARL B ) price-to-earnings (or "P/E") ratio of 16.8x right now...

Amid renewed trade and geopolitical uncertainty, the European stock market has seen declines, with the pan-European STOXX Europe 600 Index ending 0.98% lower. Despite these challenges, business activity in the eurozone remains positive, offering a glimmer of optimism for investors seeking opportunities in undervalued stocks. In this context, identifying stocks trading below their intrinsic value can be crucial for investors looking to capitalize on potential market inefficiencies and position...

With its stock down 12% over the past month, it is easy to disregard Zealand Pharma (CPH:ZEAL). However, a closer look...

Coloplast A/S' ( CPH:COLO B ) price-to-earnings (or "P/E") ratio of 33.6x might make it look like a strong sell right...

Tryg (CPH:TRYG) has had a rough month with its share price down 1.6%. However, the company's fundamentals look pretty...

RIAS A/S ( CPH:RIAS B ) has announced that on 26th of January, it will be paying a dividend ofDKK26.00, which a...

To the annoyance of some shareholders, Pandora A/S ( CPH:PNDORA ) shares are down a considerable 26% in the last month...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Hove A/S ( CPH:HOVE ) shares have continued their recent momentum with a 27% gain in the last month alone. The annual...

Brd. Klee A/S ( CPH:KLEE B ) is about to trade ex-dividend in the next three days. The ex-dividend date generally...

Novo Nordisk A/S ( CPH:NOVO B ) shares have had a really impressive month, gaining 26% after a shaky period beforehand...

Q2 2026 results snapshot Bang & Olufsen (CPSE:BO) has just posted Q2 2026 revenue of DKK 676 million, with basic EPS of DKK 0.40 loss and net income loss of DKK 53 million setting the tone for the quarter. The company has seen quarterly revenue move between DKK 544 million and DKK 698 million over the last six reported periods, while basic EPS has ranged from a profit of DKK 0.06 to a loss of DKK 0.40. This gives investors a clear view of how top line stability contrasts with ongoing earnings...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

In recent months, GN Store Nord A/S has been working to rebuild its position in audio and hearing technology by tightening costs, integrating operations more effectively, and continuing to develop its Jabra and hearing-aid product lines. This quieter turnaround effort matters because it ties GN’s professional and medical audio strengths directly to persistent trends in remote work and age-driven hearing care demand. We’ll now examine how GN Store Nord’s renewed emphasis on cost savings and...

Those holding Shape Robotics A/S ( CPH:SHAPE ) shares would be relieved that the share price has rebounded 26% in the...

To the annoyance of some shareholders, cBrain A/S ( CPH:CBRAIN ) shares are down a considerable 26% in the last month...

SP Group A/S ( CPH:SPG ) shares have continued their recent momentum with a 26% gain in the last month alone. The last...